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Research Article
Chronic Postoperative Pain After
Hysterectomy for Endometrial Cancer: A
Metabolic Profiling Study
Søren Lunde1 , Hien TT Nguyen2, Kristian K Petersen3,
Lars Arendt-Nielsen3, Henrik B Krarup2, and
Erik Søgaard-Andersen1
Abstract
Introduction: One out of seven women will develop a state of chronic postoperative pain following robot-assisted hys-
terectomy for endometrial cancer. Recently, metabolic studies have indicated that circulating lipids and lipoproteins could act
as nociceptive modulators and thereby influence the induction and perpetuation of pain. The objectives of this explorative
study were (1) to examine the preoperative serologic variations in concentrations of lipids, lipoproteins, and various low-
molecular metabolites in patients with and without chronic postoperative pain after robot-assisted hysterectomy and (2) to
explore if any of these serological biomarkers were predictive for development of chronic postoperative pain.
Materials and Methods: The study was designed as a nested case–control study within a cohort of women treated for
endometrial cancer with robot-assisted laparoscopic hysterectomy. Twenty-six women with chronic postoperative pain
were matched on age and body mass index with fifty-two controls without chronic postoperative pain, and metabolic
profiling of preoperatively drawn blood samples from a biobank was performed by means of nuclear magnetic resonance
spectroscopy.
Results: Nineteen metabolites, including cholesterol, cholesteryl ester, linoleic acid, phospholipids, lipids, and triglycerides
had statistically significant higher concentrations in a subgroup of patients who would develop chronic postoperative pain on
a later stage compared to the group of patients who would not develop chronic postoperative pain (p< 0.05). A sparse
Partial Least Squares-Discriminant Analysis model explained 38.1% of the variance and had a predictive accuracy of 73.1%.
Conclusions: This explorative study substantiates the hypothesis that certain lipids, lipoproteins, and fatty acids are asso-
ciated with chronic postoperative pain.
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Introduction
The prevalence of chronic postoperative pain is highly
procedure specific ranging from 12.3% after caesarean
section,1 20.0% after total knee replacement,2 30.0%
after hernia repair,3 47.0% after mastectomy4 and thora-
cotomy,5 and as high as 52.6% after limb amputation.6
A recent study demonstrated a prevalence of chronic
postoperative pain of 14.9% in patients undergoing
robot-assisted laparoscopic hysterectomy due to endo-
metrial cancer and identified preoperative pelvic pain
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and high levels of acute postoperative pain intensity as
independent risk factors for chronic postoperative pain.7
The surgical stress response following induced tissue
injury triggers a physiologic cascade of cytokine-
mediated immunologic and endocrinologic alterations
as well as a sympathoadrenal response with increased
cortisol secretion, thereby altering metabolism of glucose
and circulating plasma lipids.8–11 The deafferentation of
visceral nerves further elicits a release of sensitizing and
proinflammatory mediators, lowering the excitatory
threshold of nerve endings and thereby increasing the
peripheral pain sensitivity.8,12
An emerging theory in pro- and antinociceptive fac-
tors suggests that lipoproteins like polyunsaturated fatty
acids may have opposing effects on the inflammatory
and nociceptive reactions via modulation of the cellular
membrane microdomain composition.13 The theory has
further been substantiated by studies showing an associ-
ation between the occurrence of lower back pain and
certain lipid profile compositions.14,15 Likewise, an asso-
ciation between chronic pain conditions and dyslipide-
mia has been demonstrated.16–18
The objectives of this explorative study were (1) to
examine the preoperative serologic variations in concen-
trations of lipids, lipoproteins, and various low-molecu-
lar metabolites by means of nuclear magnetic resonance
(NMR) spectroscopy and (2) to explore if any of these
serological biomarkers were predictive for development
of chronic postoperative pain after robot-assisted
hysterectomy.
Materials and Methods
Design
A nested case–control study within a cohort of women
treated for endometrial cancer with robot-assisted lapa-
roscopic hysterectomy.
The Study Cohort
A recently published, questionnaire-based study defined
a cohort of two hundred and seven women from a total
of two hundred and eighty women, who all underwent
robot-assisted laparoscopic hysterectomy at The
Department of Obstetrics and Gynecology, Aalborg
University Hospital, Aalborg, Denmark from 1
January 2010 till 31 July 2015 due to endometrial
cancer.7 The study identified thirty-one women with
chronic postoperative pain (defined as persistent, mod-
erate to severe pain with a mean intensity of 3 on a
Visual Analogue Scale 6months after the surgical pro-
cedure), equal to a prevalence of 14.9% (Figure 1). The
inclusion criteria were Danish speaking women, aged 18
to 85 years, diagnosed with endometrial cancer and
scheduled for robot-assisted laparoscopic hysterectomy
and bilateral salpingo-oophorectomy, while the exclu-
sion criteria were conversion of the robot-assisted lapa-
roscopic procedure to open surgery, subsequent open
surgery, use of cannabis or opioids, and neurologic or
mental disorders.
The Treatment Algorithm and Surgical Procedure
The women were preoperatively stratified in risk catego-
ries based on the histologic type and grade according to
the joint guideline from The European Society for
Medical Oncology (ESMO), The European Society of
Gynecological Oncology (ESGO), and The European
Society for Radiotherapy and Oncology (ESTRO).19
The low-risk cases were treated with hysterectomy and
bilateral salpingo-oophorectomy, intermediate-risk cases
with additional pelvic lymphadenectomy, and high-risk
cases with additional pelvic and paraaortic lymphade-
nectomy. All surgical procedures were performed on
Da VinciTM Si robotic systems (Intuitive Surgical Inc.,
Sunnyvale, CA, USA). All cases were postoperatively
reviewed and staged at multidisciplinary tumor board
meetings.
Blood Samples from The Danish Cancer Biobank
Since 2009, all cancer patients in Denmark have been
offered to have blood and tissue samples stored in The
Danish Cancer Biobank (DCB), part of a national col-
laboration between public hospitals entitled The Bio-
and Genome Bank Denmark. Following an informed
consent, the biologic materials are stored according to
the Danish Data Protection Agency procedures.
Twenty-six of the thirty-one women with chronic post-
operative pain from the cohort had preoperatively
drawn blood samples stored in the DCB.
Matching of Cases and Controls
The twenty-six cases with chronic postoperative pain
were matched in a 1:2 ratio with fifty-two controls
from the cohort without chronic postoperative pain,
who also had preoperatively drawn blood samples
stored in the DCB. The subjects were matched on age
at the time of surgery and body mass index (BMI) in kg/
m2 (Figure 1).
The NMR Spectroscopy
The metabolic profiles and biomarkers were quantified
from serum samples using high-throughput NMR
metabolomics (Nightingale Health Ltd., Helsinki,
Finland). This method provides simultaneous quantifi-
cation of routine lipids, lipoprotein subclass profiling
with lipid concentrations within fourteen subclasses,
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fatty acid composition, and various low-molecular
metabolites, including amino acids, ketone bodies, and
gluconeogenesis-related metabolites, in molar concentra-
tion units. Details of the experimentation and applica-
tions of the NMR metabolomics platform have been
described previously elsewhere.20
Approvals
The study was approved by The North Denmark Region
Committee on Health Research Ethics (N-20150028),
The Danish Data Protection Agency (2008–58-0028),
and The Bio- and Genome Bank Denmark.
Statistical Analysis
In order to investigate any inherent clustering in the data
and reduce possible overfitting and noise, we prepro-
cessed the entire data set by using principal component
analysis (PCA). Subsequent supervised modeling by
sparse Partial Least Squares-Discriminant Analysis
(sPLS-DA) was built in order to assign the respective
metabolites for each group. The sPLS-DA algorithm
can be used to effectively reduce the number of variables
(metabolites) in high-dimensional metabolomics data
to produce robust and easy-to-interpret models.21 For
evaluation of the classification performance, fivefold
cross-validation together with the receiver operating
characteristic curve was chosen. With this model, the
error rate was calculated to evaluate the performances.
Additionally, four machine learning algorithms
(random forest, linear support vector machine,
PLS-DA, and logistic regression) were applied to devel-
op prediction models for chronic postoperative pain
based on the identified metabolomic biomarkers.
Finally, a permutation test was used to indicate whether
the specific classification model was superior to random
classifiers. All multivariate statistics, including unsuper-
vised PCA and supervised sPLS-DA, were performed
using MetaboAnalystR 2.0 packages.22
Results
Metabolic Profile Variance
To compare the overall variation of metabolic profiles
between the cases with chronic postoperative pain and
controls without chronic postoperative pain, a classifica-
tion model was built by the supervised sPLS-DA. The
sPLS-DA model built on twenty-six cases and fifty-two
controls showed no separation between the two groups
(Figure 2(a)). The validation parameters calculated for
this model had low values (data not shown).
Of the seventy-eight women in the cohort, fifty
women were classified accordingly to the ESMO-
ESGO-ESTRO guidelines as low risk, nine women as
intermediate risk, and nineteen women as high risk
based on histologic type and grade. In order to obtain
a more synchronized data set, the high-risk cases were
removed, and a second sPLS-DA model was built on the
remaining seventeen cases and forty-two controls with
low- and intermediate-risk assessment. A discrimination
between the two groups could now be seen in the sPLS-
DA score plots; even though the separation was not
complete, and regions were overlapping, there was a vis-
ible tendency that allowed for clustering of case and
control groups (Figure 2(b)). The sPLS-DA model
explained 38.1% of the variance with the first two com-
ponents and had a predictive accuracy of 73.1%.
Identification of Detected Metabolites
A total of one hundred and forty-seven metabolites were
identified and classified in ten groups of cholesterol,
glycerides and phospholipids, apolipoproteins, fatty
acids, amino acids, glycolysis-related metabolites,
ketone bodies, fluid balance, inflammation, and lipopro-
teins (see table in Supplementary material). Twenty
metabolites which belong to fatty acids, amino acids,
glycolysis-related metabolites, and lipoprotein groups
were identified as the most influential factors for the
differentiation between case and control groups. Of
these, nineteen metabolites, including branched-chain
amino acids, cholesterol, cholesteryl ester, free cholester-
ol, linoleic acid (LA), phospholipids, serum lipids, and
Figure 1. Flow chart of the study.
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triglycerides, demonstrated statistically significant higher
concentrations in the case group than in the control
group (p< 0.05), while the concentrations of glycerol
was statistically significantly lower in the case group
than in the control group (p< 0.05). A loading plot of
these twenty metabolites was constructed, showing to
which degree each metabolite contributed to the discrim-
ination between the case and control groups (Figure 3).
Fourteen of these metabolites were found to be the
leading contributing metabolites correlated to chronic
postoperative pain, based on a combination of high
loadings scores and valid area under the curve (AUC)
values (equal or higher than 0.7). These metabolites
were cholesterol in very small, very-low-density lipopro-
tein (XS-VLDL-C), free cholesterol in very small,
very-low-density lipoprotein (XS-VLDL-FC), glycerol,
isoleucine, LA, particles in very small, very-low-density
lipoprotein (XS-VLDL-P), phospholipids in very small,
very-low-density lipoprotein (XS-VLDL-PL), total lipid
in very small, very-low-density lipoprotein (XS-VLDL-
L), triglycerides in intermediate-density lipoproteins
(IDL-TG), triglycerides in large low-density lipoprotein
(L-LDL-TG), triglycerides in low-density lipoprotein
(LDL-TG), triglycerides in medium low-density lipopro-
tein (M-LDL-TG), triglycerides in small low-density
lipoprotein (S-LDL-TG), and triglycerides in very
small, low-density lipoprotein (XS-VLDL-TG). Their
detailed information was summarized in Table 1.
Figure 2. sPLS-DA score plot of the serum metabolome from the
cases with chronic postoperative pain (red dots) and controls
without chronic postoperative pain (green dots). (a) The sPLS
model was used to discriminate between twenty-six cases and
fifty-two controls. (b) The sPLS-DA model constructed for sev-
enteen cases and forty-two controls after data set was
synchronized.
Figure 3. Loading plots from the cases with chronic postopera-
tive pain and controls without chronic postoperative pain. High
concentrations are depicted as red boxes, while low concentra-
tions are depicted as green boxes.
LDL: low-density lipoproteins; IDL: intermediate-density lipopro-
teins; HDL: high-density lipoproteins; VLDL: very-low-density
lipoproteins; XS-VLDL-FC: free cholesterol in very small VLDL;
IDL-TG: triglycerides in IDL; L-LDL-TG: triglycerides in large LDL;
LDL-TG: triglycerides in LDL; M-LDL-TG: triglycerides in medium
LDL; XS-VLDL-P: concentration of very small VLDL particles;
XS-VLDL-L: total lipids in very small VLDL; S-LDL-TG: triglycer-
ides in small LDL; XS-VLDL-PL: phospholipids in very small VLDL;
XS-VLDL-TG: triglycerides in very small VLDL; XS-VLDL-C:
cholesterol in very small VLDL; LA: linoleic acid; Ile: isoleucine;
S-VLDL-C: cholesterol in small VLDL; IDL-P: concentration of IDL
particles; IDL-L: total lipids in IDL; S-VLDL-CE: cholesteryl esters
in small VLDL; Remnant-C: remnant cholesterol, that is, non-HDL,
non-LDL cholesterol; XS-VLDL-CE: cholesteryl esters in very
small VLDL.
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Prediction Models for Chronic Postoperative Pain
The fourteen metabolites mentioned above were further
applied to build prediction models for the detection of
chronic postoperative pain through four machine learn-
ing algorithms (random forest, linear support vector
machine, PLS-DA, and logistic regression). All four
algorithms exhibited high AUC values (0.79–0.87) and
coefficients of variation prediction (0.70–0.77) (Table 2).
Discussion
The present study demonstrated a significant difference
in the preoperative metabolic profile in a subgroup of
patients, who would later develop chronic postoperative
pain compared to patients without, thereby supporting
the hypothesis of circulating lipids and lipoproteins as
nociceptive modulators and possible predictors for
development of chronic postoperative pain. The predic-
tive capabilities were shown in four predictive models
using a set of fourteen metabolites of cholesterol, lip-
oproteins, and fatty acids closely correlated to chronic
postoperative pain.
The study further showed that the preoperative levels
of serum cholesterol in very small, very-low-density lipo-
protein (XS-VLDL-C) and free cholesterol in very small,
very-low-density lipoprotein (XS-VLDL-FC) were sig-
nificantly associated to chronic postoperative pain after
robot-assisted hysterectomy for endometrial cancer.
Both metabolites were approximately 22% higher in
the subgroup which developed chronic postoperative
pain compared to the subgroup that did not develop
chronic postoperative pain. This correlation between
cholesterol metabolites and chronic postoperative pain
is noteworthy, as cholesterol has been found to modulate
the nociceptive capacity of opioid receptors in the cellu-
lar membrane.23,24 Moreover, studies have shown that
animals with high cholesterol levels require less opioids
to achieve the similar analgesic effect compared to ani-
mals with low cholesterol levels.25,26 A similar, negative
correlation was shown in humans in a study of the
required opioid doses for pain management in lung
cancer patients.27
The delicate balance between pro- and antinociceptive
lipoproteins and polyunsaturated fatty acids modulates
the cellular membrane microdomain composition.13
Fatty acids can be divided into omega 3 and
omega 6 fatty acids, where the first mentioned
mainly have an antinociceptive capacity and the latter
a pronociceptive capacity.28 The principal omega 3
fatty acid derivatives are eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA), while the omega 6
fatty acid derivatives are arachidonic acid and LA.29,30 A
study by Ramsden et al.31 showed that a diet-induced
reduction in the level of circulating LA in patients suf-
fering from chronic headaches resulted in reduced fre-
quency and severity of headaches. Furthermore, a high
dietary intake of LA was shown to increase the abun-
dance of LA derivatives and reduce the abundance of
EPA and DHA, thus promoting a pronociceptive envi-
ronment in the tissue.28 Likewise, a high dietary intake
of LA was shown in rodents to induce hyperalgesia and
allodynia.29,32,33
In the present study, significantly elevated serum con-
centrations of LA and other omega-6 fatty acids were
shown in the preoperatively drawn blood samples
among patients, who would develop chronic pain post-
operatively. This indicates a preexisting, pronociceptive
serologic environment in these patients, consequently
Table 1. Area under the curve, p value, and log2 fold change for a
set of 14 metabolites.
Metabolite
Area under
the curve p value
Log2 fold
change
IDL-TG 0.80 0.01 0.37
LDL-TG 0.80 0.01 0.35
L-LDL-TG 0.80 0.01 0.35
M-LDL-TG 0.79 0.01 0.34
S-LDL-TG 0.79 0.01 0.36
XS-VLDL-FC 0.78 0.01 0.30
XS-VLDL-TG 0.76 0.01 0.40
XS-VLDL-L 0.75 0.01 0.30
XS-VLDL-P 0.75 0.01 0.26
Glycerol 0.74 0.01 –0.48
XS-VLDL-PL 0.73 0.01 0.28
XS-VLDL-C 0.73 0.01 0.28
LA 0.71 0.01 0.18
Ile 0.70 0.02 0.30
LDL: low-density lipoproteins; IDL: intermediate-density lipoproteins;
VLDL: very-low-density lipoproteins; IDL-TG: triglycerides in IDL; LDL-
TG: triglycerides in LDL; L-LDL-TG: triglycerides in large LDL; M-LDL-TG:
triglycerides in medium LDL; S-LDL-TG: triglycerides in small LDL; XS-
VLDL-FC: free cholesterol in very small VLDL; XS-VLDL-TG: triglycerides
in very small VLDL; XS-VLDL-L: total lipids in very small VLDL; XS-VLDL-
P: concentration of very small VLDL particles; XS-VLDL-PL: phospholipids
in very small VLDL; XS-VLDL-C: cholesterol in very small VLDL; LA: lin-
oleic acid; Ile: isoleucine.
Table 2. Prediction models based on a set of fourteen metabo-
lites distinguishing case from control groups.
Algorithm
Area under
the curve
Coefficient
of variation
prediction p value
PLS-DA 0.79 (0.53–0.93) 0.70 0.01
Linear support vector 0.87 (0.69–0.97) 0.77 <0.001
Logistic regression 0.80 (0.54–0.97) 0.74 0.005
Random forest 0.82 (0.70–0.93) 0.71 <0.001
Data in parentheses represent 95% confidence intervals.
PLS-DA: Partial Least Squares-Discriminant Analysis.
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increasing the susceptibility to induction and perpetua-
tion of chronic pain.
Limitations
As mentioned above, this study was of an explorative
nature. The study cohort was based on a retrospective
questionnaire which has an inherent risk of recall bias.
Moreover, there was risk of selection bias due to the
questionnaire responder/nonresponder rate.
Furthermore, it is important to note that the subgroup
analysis only contained data from the patients with low-
and intermediate-risk assessment which reduces the gen-
eralizability. Finally, the study was conducted at a single
center which also could reduce the generalizability of the
results.
Conclusion
This explorative study substantiates the hypothesis of
certain lipids, lipoproteins, polyunsaturated fatty acids,
and derivatives may be predictive for development of
chronic pain in accordance with recent studies. The pre-
sent study, however, is the first to demonstrate this asso-
ciation to chronic postoperative pain.
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